Bionet Corp (訊聯生物科技), a leading cord blood bank company, announced yesterday that it was investing in biotechnology research firm Vita Genomics Inc’s (賽亞基因科技) subsidiary in Shanghai, the first such cross-industry integration in the domestic biotechnology industry.
“Unless the biotechnology companies in Taiwan are integrated, it will be extremely difficult for us to compete with other global competitors,” Bionet chairman Chris Tsai (蔡政憲) told a media briefing yesterday.
CAPITALIZATION
With the new capital injected from Bionet, the Shanghai Genecore Biotechnologies Co (上海基康生物技術), which was acquired by the Taipei-based Vita Genomics in February 2003, will have a paid-up capital of US$7.5 million (NT$227 million).
Bionet accounts for one-seventh of the venture’s capitalization and Vita Genomics will take up the remainder.
“With the two companies now joining hands, Bionet expects our revenue from prenatal and postnatal gene examinations in China to grow to NT$1 billion in three years,” Tsai said.
Furthermore, the out-of-control medical expenses in China are expected to help boost the popularity of gene detection in that country, he said.
LISTING
The companies also plan to list Shanghai Genecore Biotechnologies on the upcoming “second board” in China.
China is preparing to launch the NASDAQ-like bourse in Shenzhen in a bid to attract high-tech start-ups to trade there.
However, Chinese authorities have not set the standards and application process yet.
“We are now waiting for the Chinese government to make the official announcement [about the second board], which should take place sometime this quarter,” Vita Genomics chief executive officer and president Ellson Chen (陳奕雄) said yesterday.
“If requirements are met, we expect to complete the listing within half a year,” Chen said.
The New Taiwan dollar is on the verge of overtaking the yuan as Asia’s best carry-trade target given its lower risk of interest-rate and currency volatility. A strategy of borrowing the New Taiwan dollar to invest in higher-yielding alternatives has generated the second-highest return over the past month among Asian currencies behind the yuan, based on the Sharpe ratio that measures risk-adjusted relative returns. The New Taiwan dollar may soon replace its Chinese peer as the region’s favored carry trade tool, analysts say, citing Beijing’s efforts to support the yuan that can create wild swings in borrowing costs. In contrast,
Nvidia Corp’s demand for advanced packaging from Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) remains strong though the kind of technology it needs is changing, Nvidia CEO Jensen Huang (黃仁勳) said yesterday, after he was asked whether the company was cutting orders. Nvidia’s most advanced artificial intelligence (AI) chip, Blackwell, consists of multiple chips glued together using a complex chip-on-wafer-on-substrate (CoWoS) advanced packaging technology offered by TSMC, Nvidia’s main contract chipmaker. “As we move into Blackwell, we will use largely CoWoS-L. Of course, we’re still manufacturing Hopper, and Hopper will use CowoS-S. We will also transition the CoWoS-S capacity to CoWos-L,” Huang said
Nvidia Corp CEO Jensen Huang (黃仁勳) is expected to miss the inauguration of US president-elect Donald Trump on Monday, bucking a trend among high-profile US technology leaders. Huang is visiting East Asia this week, as he typically does around the time of the Lunar New Year, a person familiar with the situation said. He has never previously attended a US presidential inauguration, said the person, who asked not to be identified, because the plans have not been announced. That makes Nvidia an exception among the most valuable technology companies, most of which are sending cofounders or CEOs to the event. That includes
INDUSTRY LEADER: TSMC aims to continue outperforming the industry’s growth and makes 2025 another strong growth year, chairman and CEO C.C. Wei says Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), a major chip supplier to Nvidia Corp and Apple Inc, yesterday said it aims to grow revenue by about 25 percent this year, driven by robust demand for artificial intelligence (AI) chips. That means TSMC would continue to outpace the foundry industry’s 10 percent annual growth this year based on the chipmaker’s estimate. The chipmaker expects revenue from AI-related chips to double this year, extending a three-fold increase last year. The growth would quicken over the next five years at a compound annual growth rate of 45 percent, fueled by strong demand for the high-performance computing